| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, G-Protein-Coupled | 41 | 2020 | 167 | 8.830 |
Why?
|
| Arrestins | 45 | 2020 | 92 | 8.060 |
Why?
|
| Signal Transduction | 78 | 2020 | 2689 | 5.950 |
Why?
|
| GTP-Binding Proteins | 38 | 2013 | 231 | 3.400 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 26 | 2016 | 150 | 2.850 |
Why?
|
| Mitogen-Activated Protein Kinases | 25 | 2005 | 250 | 2.670 |
Why?
|
| Receptor, Parathyroid Hormone, Type 1 | 10 | 2017 | 17 | 2.640 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 25 | 2016 | 147 | 2.500 |
Why?
|
| beta-Arrestins | 36 | 2020 | 80 | 2.410 |
Why?
|
| Arrestin | 7 | 2019 | 12 | 2.220 |
Why?
|
| Parathyroid Hormone | 7 | 2017 | 117 | 1.980 |
Why?
|
| Enzyme Activation | 45 | 2018 | 791 | 1.780 |
Why?
|
| ErbB Receptors | 20 | 2014 | 239 | 1.700 |
Why?
|
| Ligands | 17 | 2017 | 317 | 1.650 |
Why?
|
| MAP Kinase Signaling System | 12 | 2018 | 247 | 1.610 |
Why?
|
| Receptor, Angiotensin, Type 1 | 9 | 2014 | 80 | 1.510 |
Why?
|
| Animals | 104 | 2020 | 20881 | 1.400 |
Why?
|
| Receptors, Cell Surface | 17 | 2002 | 248 | 1.300 |
Why?
|
| Osteogenesis | 5 | 2019 | 152 | 1.260 |
Why?
|
| src-Family Kinases | 15 | 2014 | 91 | 1.200 |
Why?
|
| Phosphorylation | 41 | 2018 | 1200 | 1.180 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 17 | 1999 | 107 | 1.140 |
Why?
|
| Drug Design | 7 | 2017 | 107 | 1.110 |
Why?
|
| Transcriptome | 2 | 2019 | 164 | 1.020 |
Why?
|
| Angiotensin II | 13 | 2015 | 220 | 1.010 |
Why?
|
| Peptide Fragments | 7 | 2015 | 483 | 0.930 |
Why?
|
| Calcium | 8 | 2016 | 929 | 0.920 |
Why?
|
| Lysophospholipids | 9 | 2016 | 209 | 0.920 |
Why?
|
| HEK293 Cells | 13 | 2019 | 326 | 0.870 |
Why?
|
| Humans | 102 | 2020 | 68618 | 0.850 |
Why?
|
| Osteoblasts | 3 | 2019 | 99 | 0.850 |
Why?
|
| Insulin-Like Growth Factor II | 3 | 2011 | 52 | 0.770 |
Why?
|
| Drug Discovery | 2 | 2014 | 94 | 0.770 |
Why?
|
| Transcription, Genetic | 4 | 2015 | 562 | 0.760 |
Why?
|
| Gene Regulatory Networks | 3 | 2019 | 94 | 0.760 |
Why?
|
| RNA, Small Interfering | 7 | 2018 | 434 | 0.730 |
Why?
|
| Receptor, IGF Type 2 | 3 | 2011 | 13 | 0.720 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 6 | 2015 | 201 | 0.710 |
Why?
|
| Cell Line | 37 | 2014 | 1752 | 0.700 |
Why?
|
| Insulin-Like Growth Factor I | 3 | 2007 | 110 | 0.680 |
Why?
|
| Protein-Tyrosine Kinases | 10 | 2008 | 195 | 0.670 |
Why?
|
| Models, Biological | 17 | 2013 | 981 | 0.660 |
Why?
|
| Protein Binding | 13 | 2015 | 1027 | 0.640 |
Why?
|
| Transcriptional Activation | 10 | 2012 | 226 | 0.640 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 41 | 0.630 |
Why?
|
| Endocytosis | 16 | 2010 | 113 | 0.610 |
Why?
|
| Receptors, Adrenergic, beta-2 | 10 | 2018 | 34 | 0.590 |
Why?
|
| Cyclic AMP | 8 | 2013 | 223 | 0.570 |
Why?
|
| Rats | 24 | 2020 | 5300 | 0.570 |
Why?
|
| Sphingosine | 6 | 2016 | 315 | 0.570 |
Why?
|
| Jaw Neoplasms | 1 | 2016 | 4 | 0.550 |
Why?
|
| Fibroma | 1 | 2016 | 20 | 0.550 |
Why?
|
| Hypercalcemia | 1 | 2016 | 34 | 0.540 |
Why?
|
| Hyperparathyroidism | 1 | 2016 | 40 | 0.540 |
Why?
|
| Mice | 29 | 2020 | 8474 | 0.540 |
Why?
|
| Cell Differentiation | 3 | 2019 | 1034 | 0.530 |
Why?
|
| Informatics | 1 | 2015 | 3 | 0.510 |
Why?
|
| Cell Membrane | 10 | 2020 | 525 | 0.510 |
Why?
|
| Adenoma | 1 | 2016 | 132 | 0.500 |
Why?
|
| Protein Kinase C | 6 | 2011 | 270 | 0.500 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2018 | 214 | 0.490 |
Why?
|
| Epidermal Growth Factor | 11 | 2014 | 95 | 0.490 |
Why?
|
| beta-Arrestin 2 | 9 | 2020 | 29 | 0.480 |
Why?
|
| Pharmacology | 1 | 2014 | 9 | 0.460 |
Why?
|
| Muscle, Smooth, Vascular | 5 | 2014 | 317 | 0.460 |
Why?
|
| Molecular Targeted Therapy | 3 | 2016 | 170 | 0.450 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 118 | 0.450 |
Why?
|
| Proteins | 5 | 2007 | 474 | 0.440 |
Why?
|
| Vasoconstrictor Agents | 2 | 2011 | 107 | 0.440 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2013 | 22 | 0.430 |
Why?
|
| Phosphotransferases | 1 | 2013 | 16 | 0.430 |
Why?
|
| Type C Phospholipases | 4 | 2011 | 67 | 0.430 |
Why?
|
| COS Cells | 15 | 2008 | 155 | 0.420 |
Why?
|
| Transfection | 17 | 2014 | 782 | 0.420 |
Why?
|
| Myocytes, Smooth Muscle | 5 | 2014 | 144 | 0.420 |
Why?
|
| Biological Assay | 1 | 2013 | 88 | 0.410 |
Why?
|
| Molecular Biology | 2 | 2013 | 31 | 0.410 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 331 | 0.410 |
Why?
|
| Paracrine Communication | 2 | 2019 | 31 | 0.400 |
Why?
|
| Pharmaceutical Preparations | 1 | 2013 | 101 | 0.400 |
Why?
|
| Connective Tissue Growth Factor | 5 | 2018 | 76 | 0.400 |
Why?
|
| Bone and Bones | 2 | 2013 | 145 | 0.390 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 7 | 2010 | 31 | 0.390 |
Why?
|
| Receptor Cross-Talk | 5 | 2010 | 16 | 0.380 |
Why?
|
| Kinetics | 9 | 2016 | 1047 | 0.380 |
Why?
|
| Diabetes Mellitus, Type 1 | 5 | 2020 | 529 | 0.380 |
Why?
|
| Drug Industry | 1 | 2011 | 54 | 0.370 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 5 | 2014 | 175 | 0.370 |
Why?
|
| Bone Development | 2 | 2013 | 37 | 0.370 |
Why?
|
| Receptors, Lysosphingolipid | 5 | 2016 | 63 | 0.360 |
Why?
|
| Insulin | 8 | 2019 | 619 | 0.360 |
Why?
|
| Bone Density | 4 | 2019 | 159 | 0.360 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 3 | 2000 | 62 | 0.350 |
Why?
|
| ras Proteins | 7 | 2008 | 102 | 0.350 |
Why?
|
| Cells, Cultured | 16 | 2020 | 2673 | 0.350 |
Why?
|
| Receptors, Angiotensin | 3 | 2016 | 59 | 0.350 |
Why?
|
| Protein Conformation | 6 | 2016 | 362 | 0.330 |
Why?
|
| Phosphoproteins | 6 | 2018 | 202 | 0.330 |
Why?
|
| Receptors, Adiponectin | 1 | 2008 | 10 | 0.320 |
Why?
|
| Tyrosine | 8 | 2004 | 196 | 0.320 |
Why?
|
| Mice, Knockout | 8 | 2020 | 1692 | 0.310 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2019 | 320 | 0.310 |
Why?
|
| Membrane Proteins | 4 | 2010 | 617 | 0.310 |
Why?
|
| Biotechnology | 1 | 2008 | 34 | 0.300 |
Why?
|
| beta-Arrestin 1 | 8 | 2020 | 22 | 0.300 |
Why?
|
| Receptor, IGF Type 1 | 3 | 2011 | 42 | 0.300 |
Why?
|
| src Homology Domains | 6 | 2000 | 29 | 0.300 |
Why?
|
| Islets of Langerhans Transplantation | 2 | 2019 | 101 | 0.300 |
Why?
|
| RNA Interference | 6 | 2011 | 266 | 0.300 |
Why?
|
| Nerve Tissue | 1 | 2007 | 6 | 0.290 |
Why?
|
| Cattle | 5 | 2015 | 475 | 0.290 |
Why?
|
| Diabetic Angiopathies | 3 | 2015 | 203 | 0.280 |
Why?
|
| Somatomedins | 1 | 2006 | 16 | 0.280 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2006 | 6 | 0.270 |
Why?
|
| Kallikreins | 3 | 2020 | 323 | 0.270 |
Why?
|
| Protein Transport | 5 | 2016 | 280 | 0.270 |
Why?
|
| Cardiovascular Diseases | 2 | 2020 | 940 | 0.270 |
Why?
|
| Receptors, Opioid | 1 | 2006 | 60 | 0.270 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 5 | 2003 | 100 | 0.270 |
Why?
|
| Virulence Factors, Bordetella | 8 | 2000 | 60 | 0.260 |
Why?
|
| Gene Knockdown Techniques | 3 | 2018 | 196 | 0.260 |
Why?
|
| Cytosol | 2 | 2006 | 123 | 0.260 |
Why?
|
| Mesangial Cells | 3 | 2012 | 37 | 0.260 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 7 | 2006 | 93 | 0.260 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 5 | 2000 | 26 | 0.260 |
Why?
|
| Prekallikrein | 2 | 2015 | 66 | 0.250 |
Why?
|
| Tyrphostins | 6 | 2005 | 13 | 0.250 |
Why?
|
| Green Fluorescent Proteins | 5 | 2011 | 200 | 0.250 |
Why?
|
| Aging | 3 | 2020 | 911 | 0.240 |
Why?
|
| Protein Kinases | 5 | 2006 | 122 | 0.240 |
Why?
|
| Mice, Inbred C57BL | 7 | 2017 | 2791 | 0.240 |
Why?
|
| Phenylalanine | 1 | 2004 | 22 | 0.240 |
Why?
|
| Tetradecanoylphorbol Acetate | 3 | 2011 | 138 | 0.240 |
Why?
|
| Quinazolines | 6 | 2005 | 70 | 0.240 |
Why?
|
| Recombinant Proteins | 10 | 2008 | 742 | 0.240 |
Why?
|
| Osteoporosis | 2 | 2017 | 88 | 0.230 |
Why?
|
| Organ Specificity | 2 | 2015 | 167 | 0.230 |
Why?
|
| Fibroblasts | 3 | 2011 | 902 | 0.220 |
Why?
|
| Dinoprost | 1 | 2003 | 27 | 0.220 |
Why?
|
| Protein Isoforms | 5 | 2019 | 246 | 0.220 |
Why?
|
| Recombinant Fusion Proteins | 7 | 2012 | 376 | 0.220 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2000 | 82 | 0.210 |
Why?
|
| Mitogens | 2 | 2000 | 45 | 0.210 |
Why?
|
| Cell Division | 5 | 2008 | 541 | 0.210 |
Why?
|
| Gene Deletion | 3 | 2018 | 235 | 0.210 |
Why?
|
| Protein Structure, Tertiary | 5 | 2007 | 322 | 0.210 |
Why?
|
| Computational Biology | 2 | 2015 | 190 | 0.210 |
Why?
|
| Clathrin | 6 | 2008 | 17 | 0.210 |
Why?
|
| Allosteric Regulation | 2 | 2014 | 58 | 0.210 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 5 | 2010 | 146 | 0.210 |
Why?
|
| Cytoskeleton | 1 | 2002 | 84 | 0.200 |
Why?
|
| Proteomics | 2 | 2015 | 246 | 0.200 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 498 | 0.200 |
Why?
|
| Liver Diseases | 2 | 2020 | 193 | 0.200 |
Why?
|
| Models, Molecular | 3 | 2017 | 546 | 0.190 |
Why?
|
| Cell Proliferation | 4 | 2014 | 1174 | 0.190 |
Why?
|
| Neurons | 1 | 2007 | 881 | 0.190 |
Why?
|
| Actins | 1 | 2002 | 249 | 0.190 |
Why?
|
| Gene Expression Regulation | 5 | 2013 | 1293 | 0.190 |
Why?
|
| 3T3 Cells | 3 | 2019 | 124 | 0.180 |
Why?
|
| ADAM Proteins | 3 | 2010 | 53 | 0.180 |
Why?
|
| Bacterial Toxins | 1 | 2000 | 50 | 0.170 |
Why?
|
| Diabetic Nephropathies | 3 | 2012 | 161 | 0.170 |
Why?
|
| Carbon Monoxide | 1 | 2019 | 58 | 0.170 |
Why?
|
| Pertussis Toxin | 4 | 1997 | 72 | 0.170 |
Why?
|
| Male | 17 | 2020 | 37321 | 0.170 |
Why?
|
| Receptors, Adrenergic, beta-1 | 2 | 2013 | 7 | 0.170 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2020 | 102 | 0.160 |
Why?
|
| Bioluminescence Resonance Energy Transfer Techniques | 1 | 2019 | 8 | 0.160 |
Why?
|
| Fluorescein | 1 | 2019 | 15 | 0.160 |
Why?
|
| Datasets as Topic | 1 | 2019 | 53 | 0.160 |
Why?
|
| Autocrine Communication | 1 | 2019 | 37 | 0.160 |
Why?
|
| Bone Remodeling | 1 | 2019 | 45 | 0.160 |
Why?
|
| Receptors, Adrenergic, alpha | 3 | 2000 | 40 | 0.160 |
Why?
|
| Arsenic | 1 | 2019 | 46 | 0.160 |
Why?
|
| Biosensing Techniques | 1 | 2019 | 51 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2018 | 1085 | 0.160 |
Why?
|
| Gene Editing | 1 | 2018 | 33 | 0.160 |
Why?
|
| Receptors, Catecholamine | 1 | 1998 | 2 | 0.150 |
Why?
|
| GTPase-Activating Proteins | 1 | 2018 | 21 | 0.150 |
Why?
|
| Pancreatitis, Chronic | 1 | 2019 | 168 | 0.150 |
Why?
|
| Bacterial Proteins | 1 | 2000 | 245 | 0.150 |
Why?
|
| Up-Regulation | 2 | 2012 | 682 | 0.150 |
Why?
|
| Receptors, Muscarinic | 3 | 1996 | 44 | 0.150 |
Why?
|
| RGS Proteins | 1 | 2017 | 22 | 0.150 |
Why?
|
| Cell Size | 1 | 2017 | 76 | 0.150 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2013 | 1745 | 0.140 |
Why?
|
| Hydrolysis | 3 | 2002 | 144 | 0.140 |
Why?
|
| Dimerization | 3 | 2013 | 99 | 0.140 |
Why?
|
| In Vitro Techniques | 3 | 2017 | 765 | 0.140 |
Why?
|
| Drug Therapy | 2 | 2009 | 71 | 0.140 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2017 | 63 | 0.140 |
Why?
|
| Insulin-Secreting Cells | 1 | 2017 | 41 | 0.140 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2016 | 18 | 0.140 |
Why?
|
| Base Sequence | 6 | 2010 | 1015 | 0.140 |
Why?
|
| Calcimimetic Agents | 1 | 2016 | 2 | 0.140 |
Why?
|
| Prostatic Neoplasms | 2 | 2000 | 778 | 0.140 |
Why?
|
| Calcitonin | 1 | 2016 | 21 | 0.140 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2020 | 2083 | 0.140 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2014 | 284 | 0.140 |
Why?
|
| Adenocarcinoma | 1 | 1999 | 475 | 0.140 |
Why?
|
| Adipocytes | 3 | 2010 | 88 | 0.140 |
Why?
|
| Peritoneal Fibrosis | 1 | 2016 | 2 | 0.140 |
Why?
|
| Lipoproteins, HDL | 1 | 2016 | 113 | 0.140 |
Why?
|
| Parathyroidectomy | 1 | 2016 | 45 | 0.130 |
Why?
|
| Models, Animal | 1 | 2017 | 252 | 0.130 |
Why?
|
| Receptors, Dopamine D1 | 2 | 1994 | 87 | 0.130 |
Why?
|
| Peritoneal Dialysis | 1 | 2016 | 30 | 0.130 |
Why?
|
| Blood Proteins | 2 | 1997 | 94 | 0.130 |
Why?
|
| Sodium-Hydrogen Exchangers | 2 | 2014 | 43 | 0.130 |
Why?
|
| Aorta | 3 | 2016 | 316 | 0.130 |
Why?
|
| Isoproterenol | 7 | 2003 | 163 | 0.130 |
Why?
|
| Receptor, Bradykinin B2 | 2 | 2013 | 75 | 0.130 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2015 | 54 | 0.130 |
Why?
|
| Pancreatitis | 1 | 2017 | 279 | 0.130 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 493 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2001 | 411 | 0.130 |
Why?
|
| Models, Statistical | 1 | 2018 | 448 | 0.120 |
Why?
|
| Calcium Channels | 1 | 2015 | 59 | 0.120 |
Why?
|
| Microscopy, Confocal | 3 | 2009 | 337 | 0.120 |
Why?
|
| Arthritis, Infectious | 1 | 1994 | 14 | 0.120 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 139 | 0.120 |
Why?
|
| Phosphatidylinositols | 4 | 2002 | 40 | 0.120 |
Why?
|
| Mutation | 6 | 2008 | 1213 | 0.120 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2014 | 16 | 0.120 |
Why?
|
| Mycoplasma Infections | 1 | 1994 | 40 | 0.120 |
Why?
|
| Cell Nucleus | 3 | 2020 | 305 | 0.120 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2014 | 32 | 0.120 |
Why?
|
| Species Specificity | 1 | 2015 | 303 | 0.120 |
Why?
|
| Protein Subunits | 2 | 2006 | 99 | 0.120 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2014 | 39 | 0.120 |
Why?
|
| Maleimides | 2 | 2011 | 15 | 0.120 |
Why?
|
| Biological Transport | 4 | 2016 | 210 | 0.120 |
Why?
|
| Kidney Tubules, Collecting | 1 | 2014 | 46 | 0.120 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 56 | 0.120 |
Why?
|
| Diglycerides | 3 | 2011 | 49 | 0.110 |
Why?
|
| Protein Biosynthesis | 1 | 2014 | 181 | 0.110 |
Why?
|
| GTP Phosphohydrolases | 4 | 2002 | 46 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 2 | 2013 | 261 | 0.110 |
Why?
|
| Bradykinin | 2 | 2014 | 157 | 0.110 |
Why?
|
| Enzyme Inhibitors | 8 | 2005 | 659 | 0.110 |
Why?
|
| Receptors, Adrenergic, beta | 5 | 2003 | 153 | 0.110 |
Why?
|
| Muscles | 2 | 1990 | 158 | 0.110 |
Why?
|
| Teriparatide | 1 | 2013 | 7 | 0.110 |
Why?
|
| NF-kappa B | 2 | 2013 | 432 | 0.110 |
Why?
|
| Time-Lapse Imaging | 1 | 2013 | 8 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2014 | 194 | 0.110 |
Why?
|
| Indoles | 2 | 2011 | 146 | 0.110 |
Why?
|
| Heparin | 2 | 2006 | 205 | 0.110 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 1140 | 0.110 |
Why?
|
| Adult | 8 | 2020 | 21403 | 0.110 |
Why?
|
| Luciferases | 1 | 2013 | 105 | 0.110 |
Why?
|
| CHO Cells | 7 | 2010 | 161 | 0.110 |
Why?
|
| Cricetinae | 7 | 2010 | 262 | 0.110 |
Why?
|
| Genes, Reporter | 1 | 2013 | 191 | 0.100 |
Why?
|
| Myocardial Infarction | 1 | 2018 | 807 | 0.100 |
Why?
|
| Down-Regulation | 3 | 2005 | 447 | 0.100 |
Why?
|
| Bias | 1 | 2013 | 148 | 0.100 |
Why?
|
| Receptors, Lysophosphatidic Acid | 3 | 2003 | 5 | 0.100 |
Why?
|
| Enzyme Activators | 1 | 2011 | 14 | 0.100 |
Why?
|
| Protein Kinase C beta | 1 | 2011 | 19 | 0.100 |
Why?
|
| Treatment Outcome | 2 | 2016 | 7029 | 0.100 |
Why?
|
| Drug Partial Agonism | 1 | 2011 | 2 | 0.100 |
Why?
|
| Mice, Transgenic | 4 | 2014 | 1033 | 0.100 |
Why?
|
| Histone Chaperones | 1 | 2011 | 11 | 0.100 |
Why?
|
| Arthritis, Experimental | 1 | 2011 | 38 | 0.100 |
Why?
|
| Cyclooxygenase 1 | 1 | 2011 | 29 | 0.100 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2011 | 57 | 0.100 |
Why?
|
| Cyclooxygenase 2 | 2 | 2009 | 160 | 0.100 |
Why?
|
| Biological Products | 1 | 2012 | 78 | 0.100 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2013 | 307 | 0.100 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2011 | 64 | 0.090 |
Why?
|
| Glycoproteins | 2 | 2010 | 238 | 0.090 |
Why?
|
| Protein Phosphatase 2 | 1 | 2011 | 67 | 0.090 |
Why?
|
| Substrate Specificity | 1 | 2011 | 234 | 0.090 |
Why?
|
| Receptor, PAR-2 | 1 | 2010 | 7 | 0.090 |
Why?
|
| Receptor, PAR-1 | 1 | 2010 | 30 | 0.090 |
Why?
|
| Shc Signaling Adaptor Proteins | 3 | 2000 | 26 | 0.090 |
Why?
|
| Global Health | 1 | 2011 | 136 | 0.090 |
Why?
|
| Lipoproteins, HDL2 | 1 | 2010 | 4 | 0.090 |
Why?
|
| Lipoproteins, HDL3 | 1 | 2010 | 4 | 0.090 |
Why?
|
| GTP-Binding Protein Regulators | 1 | 2010 | 8 | 0.090 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2009 | 282 | 0.090 |
Why?
|
| Software | 1 | 2013 | 418 | 0.090 |
Why?
|
| Dinoprostone | 1 | 2011 | 110 | 0.090 |
Why?
|
| Cell Membrane Permeability | 1 | 2010 | 59 | 0.090 |
Why?
|
| Vitamin D Deficiency | 1 | 2013 | 292 | 0.090 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 2 | 2007 | 7 | 0.090 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2010 | 58 | 0.090 |
Why?
|
| Amino Acid Sequence | 7 | 2008 | 1083 | 0.090 |
Why?
|
| Binding Sites | 6 | 2009 | 631 | 0.090 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2011 | 157 | 0.090 |
Why?
|
| Research | 1 | 2011 | 214 | 0.090 |
Why?
|
| Lipoproteins, LDL | 1 | 2012 | 343 | 0.090 |
Why?
|
| Cell Physiological Phenomena | 1 | 2009 | 19 | 0.080 |
Why?
|
| Inflammation | 3 | 2011 | 1030 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2009 | 5 | 0.080 |
Why?
|
| Cohort Studies | 4 | 2020 | 2358 | 0.080 |
Why?
|
| Adaptor Protein Complex 2 | 1 | 2008 | 3 | 0.080 |
Why?
|
| Podocytes | 1 | 2010 | 113 | 0.080 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 2 | 2006 | 10 | 0.080 |
Why?
|
| Vitamin D | 1 | 2013 | 516 | 0.080 |
Why?
|
| Adiponectin | 1 | 2008 | 52 | 0.080 |
Why?
|
| DNA, Complementary | 2 | 2006 | 251 | 0.080 |
Why?
|
| Female | 9 | 2020 | 38074 | 0.080 |
Why?
|
| Islets of Langerhans | 2 | 2019 | 87 | 0.080 |
Why?
|
| Inositol Phosphates | 4 | 1998 | 28 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 615 | 0.080 |
Why?
|
| Lysosomes | 1 | 2009 | 136 | 0.080 |
Why?
|
| raf Kinases | 1 | 2007 | 6 | 0.080 |
Why?
|
| Pyruvate Dehydrogenase Complex | 2 | 1988 | 9 | 0.080 |
Why?
|
| Immediate-Early Proteins | 1 | 2008 | 63 | 0.080 |
Why?
|
| Molecular Sequence Data | 7 | 2005 | 1447 | 0.080 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2007 | 34 | 0.080 |
Why?
|
| Genetic Variation | 1 | 2009 | 220 | 0.080 |
Why?
|
| Pancreatectomy | 2 | 2019 | 129 | 0.080 |
Why?
|
| Glucose | 2 | 2017 | 307 | 0.070 |
Why?
|
| Time Factors | 4 | 2019 | 4655 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2019 | 231 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 627 | 0.070 |
Why?
|
| Sepsis | 1 | 2010 | 233 | 0.070 |
Why?
|
| Flavonoids | 2 | 2005 | 109 | 0.070 |
Why?
|
| Nuclear Localization Signals | 1 | 2006 | 5 | 0.070 |
Why?
|
| Glycogen Synthase | 1 | 1986 | 5 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2011 | 700 | 0.070 |
Why?
|
| Structure-Activity Relationship | 2 | 2006 | 420 | 0.070 |
Why?
|
| Hexoses | 1 | 1986 | 5 | 0.070 |
Why?
|
| Risk Factors | 4 | 2020 | 5731 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2011 | 753 | 0.070 |
Why?
|
| Ubiquitin | 1 | 2007 | 74 | 0.070 |
Why?
|
| Receptors, Adrenergic | 1 | 2006 | 68 | 0.070 |
Why?
|
| Receptors, LHRH | 1 | 2005 | 5 | 0.070 |
Why?
|
| Protein Structure, Secondary | 5 | 2003 | 136 | 0.070 |
Why?
|
| Blood Vessels | 1 | 2006 | 102 | 0.070 |
Why?
|
| Binding, Competitive | 2 | 2003 | 165 | 0.070 |
Why?
|
| Hypertension | 1 | 2015 | 1535 | 0.060 |
Why?
|
| Myocytes, Cardiac | 2 | 2006 | 442 | 0.060 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2006 | 89 | 0.060 |
Why?
|
| ADAM17 Protein | 3 | 2010 | 28 | 0.060 |
Why?
|
| Middle Aged | 6 | 2019 | 21147 | 0.060 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2005 | 10 | 0.060 |
Why?
|
| Epitopes | 1 | 2005 | 146 | 0.060 |
Why?
|
| Parathyroid Glands | 1 | 2005 | 22 | 0.060 |
Why?
|
| Models, Theoretical | 1 | 2008 | 384 | 0.060 |
Why?
|
| Guanosine Triphosphate | 2 | 1998 | 65 | 0.060 |
Why?
|
| Receptors, Somatomedin | 1 | 2004 | 7 | 0.060 |
Why?
|
| Metalloendopeptidases | 1 | 2004 | 67 | 0.060 |
Why?
|
| beta-Adrenergic Receptor Kinases | 3 | 2000 | 7 | 0.060 |
Why?
|
| RNA | 1 | 2005 | 171 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 2006 | 271 | 0.060 |
Why?
|
| Thiophenes | 1 | 2004 | 76 | 0.060 |
Why?
|
| Receptors, Adrenergic, beta-3 | 2 | 2000 | 4 | 0.060 |
Why?
|
| Peptides | 2 | 2009 | 455 | 0.060 |
Why?
|
| Blotting, Western | 3 | 2011 | 954 | 0.060 |
Why?
|
| Valine | 1 | 2003 | 43 | 0.060 |
Why?
|
| Proportional Hazards Models | 2 | 2018 | 792 | 0.060 |
Why?
|
| Receptors, Prostaglandin | 1 | 2003 | 74 | 0.050 |
Why?
|
| Blood Pressure | 3 | 2015 | 1451 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 57 | 0.050 |
Why?
|
| Vasopressins | 1 | 2002 | 33 | 0.050 |
Why?
|
| Receptors, Serotonin | 2 | 2001 | 74 | 0.050 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2003 | 155 | 0.050 |
Why?
|
| RNA, Messenger | 3 | 2014 | 1664 | 0.050 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2003 | 189 | 0.050 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2002 | 19 | 0.050 |
Why?
|
| Blood Glucose | 2 | 2017 | 631 | 0.050 |
Why?
|
| TNF Receptor-Associated Factor 3 | 1 | 2002 | 1 | 0.050 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 2 | 1999 | 47 | 0.050 |
Why?
|
| Adolescent | 4 | 2019 | 8912 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 2000 | 852 | 0.050 |
Why?
|
| Aged | 4 | 2019 | 14862 | 0.050 |
Why?
|
| Muscle Proteins | 1 | 2001 | 94 | 0.050 |
Why?
|
| Glomerular Mesangium | 1 | 2001 | 53 | 0.050 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2000 | 10 | 0.050 |
Why?
|
| GRB2 Adaptor Protein | 2 | 1997 | 13 | 0.050 |
Why?
|
| Young Adult | 3 | 2020 | 5717 | 0.050 |
Why?
|
| Liver | 2 | 2020 | 1118 | 0.050 |
Why?
|
| Protein Interaction Maps | 1 | 2020 | 30 | 0.050 |
Why?
|
| Macromolecular Substances | 3 | 2003 | 122 | 0.050 |
Why?
|
| Quality of Life | 2 | 2019 | 1515 | 0.040 |
Why?
|
| Endothelin-1 | 1 | 2001 | 122 | 0.040 |
Why?
|
| Receptors for Activated C Kinase | 1 | 2000 | 5 | 0.040 |
Why?
|
| Dynamins | 4 | 2002 | 14 | 0.040 |
Why?
|
| Chemokines, CC | 1 | 2019 | 18 | 0.040 |
Why?
|
| EGF Family of Proteins | 2 | 2010 | 17 | 0.040 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 1997 | 78 | 0.040 |
Why?
|
| Amphiregulin | 2 | 2010 | 19 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2019 | 75 | 0.040 |
Why?
|
| Glucose Intolerance | 1 | 2019 | 36 | 0.040 |
Why?
|
| Hypertension, Portal | 1 | 2020 | 53 | 0.040 |
Why?
|
| Chemokine CXCL12 | 1 | 2019 | 51 | 0.040 |
Why?
|
| Hepatic Stellate Cells | 1 | 2020 | 53 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2019 | 145 | 0.040 |
Why?
|
| Protein Domains | 1 | 2019 | 74 | 0.040 |
Why?
|
| PC12 Cells | 1 | 1999 | 36 | 0.040 |
Why?
|
| Thrombin | 1 | 2000 | 117 | 0.040 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 1999 | 18 | 0.040 |
Why?
|
| Adrenergic beta-Agonists | 4 | 2000 | 92 | 0.040 |
Why?
|
| Calmodulin | 1 | 1999 | 53 | 0.040 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2019 | 109 | 0.040 |
Why?
|
| Microtubules | 1 | 1999 | 104 | 0.040 |
Why?
|
| Oligopeptides | 1 | 1999 | 152 | 0.040 |
Why?
|
| Cloning, Molecular | 2 | 2003 | 357 | 0.040 |
Why?
|
| Diabetes Mellitus | 2 | 2017 | 694 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2019 | 193 | 0.040 |
Why?
|
| Guanosine Diphosphate | 1 | 1998 | 12 | 0.040 |
Why?
|
| Src Homology 2 Domain-Containing, Transforming Protein 1 | 1 | 1997 | 15 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2011 | 626 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2020 | 382 | 0.040 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 1997 | 27 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 1999 | 324 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2018 | 3705 | 0.040 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 1997 | 20 | 0.040 |
Why?
|
| Endpoint Determination | 1 | 2018 | 82 | 0.040 |
Why?
|
| Adenylyl Cyclases | 2 | 1994 | 94 | 0.040 |
Why?
|
| Myocardium | 2 | 1998 | 1204 | 0.040 |
Why?
|
| Cytoprotection | 1 | 2017 | 39 | 0.040 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 1998 | 140 | 0.040 |
Why?
|
| Cell Hypoxia | 1 | 2017 | 92 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1054 | 0.040 |
Why?
|
| Neurodegenerative Diseases | 1 | 2018 | 102 | 0.040 |
Why?
|
| Globins | 2 | 1994 | 13 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 2017 | 138 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 1997 | 199 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1994 | 35 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2016 | 122 | 0.030 |
Why?
|
| Cytoplasm | 2 | 1994 | 155 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 230 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2017 | 215 | 0.030 |
Why?
|
| Homeostasis | 1 | 2017 | 291 | 0.030 |
Why?
|
| Plasmids | 2 | 1994 | 258 | 0.030 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 1995 | 7 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 2550 | 0.030 |
Why?
|
| Cytokines | 1 | 2019 | 866 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2015 | 100 | 0.030 |
Why?
|
| Peptide Mapping | 2 | 1999 | 39 | 0.030 |
Why?
|
| Mycoplasma | 1 | 1994 | 10 | 0.030 |
Why?
|
| Synovial Fluid | 1 | 1994 | 16 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2018 | 706 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2009 | 282 | 0.030 |
Why?
|
| Point Mutation | 3 | 2000 | 97 | 0.030 |
Why?
|
| Joint Diseases | 1 | 1994 | 37 | 0.030 |
Why?
|
| Doxycycline | 1 | 1994 | 49 | 0.030 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 1 | 1994 | 12 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 1994 | 164 | 0.030 |
Why?
|
| Protease Inhibitors | 1 | 2014 | 76 | 0.030 |
Why?
|
| Cholesterol | 1 | 2015 | 331 | 0.030 |
Why?
|
| Knee Joint | 1 | 1994 | 115 | 0.030 |
Why?
|
| Phenotype | 1 | 2017 | 947 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 521 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 1342 | 0.030 |
Why?
|
| Cilia | 1 | 2014 | 94 | 0.030 |
Why?
|
| Losartan | 1 | 2013 | 45 | 0.030 |
Why?
|
| Allosteric Site | 1 | 2013 | 17 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 2077 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 1996 | 597 | 0.030 |
Why?
|
| Semantics | 1 | 2013 | 37 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2014 | 308 | 0.030 |
Why?
|
| Shoulder Joint | 1 | 1994 | 110 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2013 | 37 | 0.030 |
Why?
|
| Automation | 1 | 2013 | 45 | 0.030 |
Why?
|
| Game Theory | 1 | 2012 | 7 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 1046 | 0.030 |
Why?
|
| Muscarinic Antagonists | 1 | 1993 | 54 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2012 | 38 | 0.030 |
Why?
|
| Genomics | 1 | 2013 | 168 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2015 | 867 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 1993 | 166 | 0.030 |
Why?
|
| Propranolol | 2 | 2003 | 103 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 331 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2013 | 230 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2012 | 137 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 2800 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2011 | 120 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 3259 | 0.020 |
Why?
|
| Aorta, Thoracic | 1 | 2013 | 211 | 0.020 |
Why?
|
| Dyslipidemias | 1 | 2012 | 98 | 0.020 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1990 | 35 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 209 | 0.020 |
Why?
|
| Phosphotyrosine | 1 | 1990 | 41 | 0.020 |
Why?
|
| Receptors, Thrombin | 1 | 2010 | 18 | 0.020 |
Why?
|
| Polyribosomes | 1 | 2010 | 24 | 0.020 |
Why?
|
| Protein Sorting Signals | 1 | 2010 | 11 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2013 | 880 | 0.020 |
Why?
|
| ELAV-Like Protein 1 | 1 | 2010 | 18 | 0.020 |
Why?
|
| ELAV Proteins | 1 | 2010 | 17 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 2010 | 71 | 0.020 |
Why?
|
| Smad1 Protein | 1 | 2010 | 10 | 0.020 |
Why?
|
| Obesity | 1 | 2018 | 1076 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2010 | 30 | 0.020 |
Why?
|
| Peritoneal Cavity | 1 | 2010 | 25 | 0.020 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2010 | 25 | 0.020 |
Why?
|
| Receptor, Insulin | 1 | 1990 | 71 | 0.020 |
Why?
|
| Cricetulus | 1 | 2010 | 98 | 0.020 |
Why?
|
| Blood | 1 | 2010 | 40 | 0.020 |
Why?
|
| Peroxidase | 1 | 2010 | 40 | 0.020 |
Why?
|
| Dioxoles | 2 | 2000 | 8 | 0.020 |
Why?
|
| Cecum | 1 | 2010 | 39 | 0.020 |
Why?
|
| Veterans | 1 | 2018 | 904 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2015 | 1330 | 0.020 |
Why?
|
| Apoptosis | 1 | 2017 | 1641 | 0.020 |
Why?
|
| Internet | 1 | 2013 | 390 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2013 | 705 | 0.020 |
Why?
|
| Macrophages, Peritoneal | 1 | 2010 | 67 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2013 | 362 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2010 | 207 | 0.020 |
Why?
|
| Cell Movement | 1 | 2013 | 630 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2010 | 159 | 0.020 |
Why?
|
| Cell Survival | 1 | 2013 | 901 | 0.020 |
Why?
|
| Disease | 1 | 2009 | 41 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2010 | 144 | 0.020 |
Why?
|
| 1-Sarcosine-8-Isoleucine Angiotensin II | 1 | 2009 | 5 | 0.020 |
Why?
|
| Spleen | 1 | 2010 | 301 | 0.020 |
Why?
|
| Wasp Venoms | 1 | 2009 | 8 | 0.020 |
Why?
|
| Phosphoserine | 1 | 1989 | 14 | 0.020 |
Why?
|
| Logistic Models | 1 | 2013 | 1420 | 0.020 |
Why?
|
| Kidney Glomerulus | 1 | 2010 | 155 | 0.020 |
Why?
|
| Clathrin-Coated Vesicles | 1 | 2008 | 1 | 0.020 |
Why?
|
| Adaptor Protein Complex beta Subunits | 1 | 2008 | 2 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 536 | 0.020 |
Why?
|
| Incidence | 1 | 2013 | 1603 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2008 | 21 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2009 | 85 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2010 | 330 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2010 | 215 | 0.020 |
Why?
|
| Glycolipids | 1 | 1988 | 20 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2010 | 714 | 0.020 |
Why?
|
| Genotype | 1 | 2010 | 786 | 0.020 |
Why?
|
| Prognosis | 1 | 2013 | 2093 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 2008 | 110 | 0.020 |
Why?
|
| Biomarkers | 1 | 2013 | 1593 | 0.020 |
Why?
|
| Albuminuria | 1 | 2008 | 171 | 0.020 |
Why?
|
| Sphingolipids | 1 | 2010 | 337 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2008 | 179 | 0.020 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1986 | 18 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2008 | 274 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2006 | 55 | 0.020 |
Why?
|
| DNA | 2 | 2006 | 597 | 0.020 |
Why?
|
| Interleukins | 1 | 2007 | 79 | 0.020 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2006 | 42 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 1986 | 134 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2013 | 2007 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 786 | 0.020 |
Why?
|
| Heparin-binding EGF-like Growth Factor | 1 | 2006 | 17 | 0.020 |
Why?
|
| Cell Cycle | 1 | 1988 | 312 | 0.020 |
Why?
|
| Macrophages | 1 | 2010 | 647 | 0.020 |
Why?
|
| Ceramides | 1 | 2010 | 578 | 0.020 |
Why?
|
| Adenylate Cyclase Toxin | 2 | 1997 | 12 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2010 | 597 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2006 | 35 | 0.020 |
Why?
|
| Isoquinolines | 1 | 2006 | 37 | 0.020 |
Why?
|
| Xenopus | 1 | 2005 | 30 | 0.020 |
Why?
|
| Cell Compartmentation | 1 | 2005 | 41 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2006 | 132 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2006 | 254 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 1988 | 370 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 1851 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2005 | 237 | 0.020 |
Why?
|
| G-Protein-Coupled Receptor Kinase 4 | 1 | 2005 | 4 | 0.020 |
Why?
|
| Lung | 1 | 2010 | 849 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2006 | 141 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2007 | 455 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2005 | 166 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase Type II | 2 | 1994 | 2 | 0.010 |
Why?
|
| Dobutamine | 1 | 2003 | 25 | 0.010 |
Why?
|
| Valsartan | 1 | 2003 | 99 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2003 | 89 | 0.010 |
Why?
|
| DNA Primers | 1 | 2003 | 302 | 0.010 |
Why?
|
| Tetrazoles | 1 | 2003 | 160 | 0.010 |
Why?
|
| Dynamin I | 1 | 2002 | 1 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 2003 | 383 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-yes | 1 | 2001 | 2 | 0.010 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2001 | 34 | 0.010 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2001 | 54 | 0.010 |
Why?
|
| Heart Rate | 1 | 2003 | 568 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2001 | 147 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2000 | 51 | 0.010 |
Why?
|
| Proline | 1 | 2000 | 52 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2000 | 45 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2000 | 77 | 0.010 |
Why?
|
| United States | 1 | 2013 | 7367 | 0.010 |
Why?
|
| Dihydrotestosterone | 1 | 2000 | 13 | 0.010 |
Why?
|
| Brimonidine Tartrate | 1 | 2000 | 13 | 0.010 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2000 | 57 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2000 | 99 | 0.010 |
Why?
|
| Quinoxalines | 1 | 2000 | 78 | 0.010 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 1999 | 22 | 0.010 |
Why?
|
| Lipolysis | 1 | 1999 | 13 | 0.010 |
Why?
|
| Receptors, Serotonin, 5-HT1 | 1 | 1999 | 12 | 0.010 |
Why?
|
| Feedback | 1 | 1999 | 90 | 0.010 |
Why?
|
| Serine | 1 | 1999 | 99 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1999 | 88 | 0.010 |
Why?
|
| Phenylephrine | 1 | 1998 | 61 | 0.010 |
Why?
|
| Transgenes | 1 | 1998 | 92 | 0.010 |
Why?
|
| Atrial Natriuretic Factor | 1 | 1998 | 54 | 0.010 |
Why?
|
| Gene Targeting | 1 | 1998 | 58 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1999 | 381 | 0.010 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 1997 | 9 | 0.010 |
Why?
|
| Ventricular Pressure | 1 | 1998 | 82 | 0.010 |
Why?
|
| Chromones | 1 | 1996 | 33 | 0.010 |
Why?
|
| Androstadienes | 1 | 1996 | 41 | 0.010 |
Why?
|
| Morpholines | 1 | 1996 | 79 | 0.010 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1996 | 19 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1996 | 60 | 0.010 |
Why?
|
| Son of Sevenless Proteins | 1 | 1995 | 4 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 1996 | 223 | 0.010 |
Why?
|
| Models, Structural | 1 | 1994 | 22 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 1994 | 20 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1994 | 26 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 1994 | 109 | 0.010 |
Why?
|
| Epinephrine | 1 | 1994 | 103 | 0.010 |
Why?
|
| Circular Dichroism | 1 | 1994 | 99 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1994 | 492 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 1988 | 71 | 0.000 |
Why?
|
| Extracellular Space | 1 | 1988 | 121 | 0.000 |
Why?
|
| Mitosis | 1 | 1988 | 76 | 0.000 |
Why?
|